BIOGEN INC. — Operating Income by Fiscal Year
15 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/3002818a-d175-43b5-8669-7acbec57e320/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2021 | $2.8B | 2021-01-01 – 2021-12-31 | evidence 0000875045-22-000007 |
| FY 2020 | $4.6B | 2020-01-01 – 2020-12-31 | evidence 0000875045-21-000010 |
| FY 2019 | $7.0B | 2019-01-01 – 2019-12-31 | evidence 0000875045-20-000005 |
| FY 2018 | $5.9B | 2018-01-01 – 2018-12-31 | evidence 0000875045-19-000006 |
| FY 2017 | $5.3B | 2017-01-01 – 2017-12-31 | evidence 0000875045-19-000006 |
| FY 2016 | $5.2B | 2016-01-01 – 2016-12-31 | evidence 0000875045-19-000006 |
| FY 2015 | $4.9B | 2015-01-01 – 2015-12-31 | evidence 0000875045-16-000042 |
| FY 2014 | $4.0B | 2014-01-01 – 2014-12-31 | evidence 0000875045-16-000042 |
| FY 2013 | $2.5B | 2013-01-01 – 2013-12-31 | evidence 0000875045-16-000042 |
| FY 2012 | $1.9B | 2012-01-01 – 2012-12-31 | evidence 0000875045-13-000006 |
| FY 2011 | $1.7B | 2011-01-01 – 2011-12-31 | evidence 0001193125-12-039072 |
| FY 2010 | $1.2B | 2010-01-01 – 2010-12-31 | evidence 0000950123-11-009300 |
| FY 2009 | $1.3B | 2009-01-01 – 2009-12-31 | evidence 0000950123-10-010528 |
| FY 2008 | $1.2B | 2008-01-01 – 2008-12-31 | evidence 0000950123-10-010528 |
| FY 2007 | $779.8M | 2007-01-01 – 2007-12-31 | evidence 0000950123-10-010528 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).